Everest Organics Profit & Loss Annual

BSE: 524790 | NSE: - | ISIN: INE334C01029 | Sector: Biotechnology & Drugs

142.80 +7.20 (5.31%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	197.24	183.05	200.05	181.57
Total Revenue	197.24	183.05	200.05	181.57
Costof Revenue Total	123.97	149.63	161.33	128.45
Gross Profit	73.27	33.42	38.71	53.11
Selling/ General/ Admin Expenses Total	18.80	31.70	29.96	28.57
Depreciation/ Amortization	5.80	4.47	3.80	3.37
Unusual Expense( Income)	0.00	0.00	0.00	-
Other Operating Expenses Total	43.48	0.04	0.74	0.41
Total Operating Expense	192.05	186.15	197.30	162.03
Operating Income	5.19	-3.10	2.74	19.54
Interest Inc( Exp) Net- Non- Op Total	-54.67	-23.13	-20.64	-15.31
Other Net	0.89	5.45	1.06	-0.74
Net Income Before Taxes	0.61	0.09	1.74	17.27
Provisionfor Income Taxes	0.47	0.27	0.60	3.56
Net Income After Taxes	0.14	-0.18	1.14	13.71
Minority Interest	0.00	-	-	-
Net Income Before Extra Items	0.14	-0.18	1.14	13.71
Total Extraordinary Items	0.00	0.00	-	-
Net Income	0.14	-0.18	1.14	13.71
Income Availableto Com Excl Extra Ord	0.14	-0.18	1.14	13.71
Income Availableto Com Incl Extra Ord	0.14	-0.18	1.14	13.71
Diluted Net Income	0.14	-0.18	1.14	13.71
Diluted Weighted Average Shares	0.82	0.79	0.80	0.80
Diluted EPS Excluding Extra Ord Items	0.17	-0.23	1.43	17.14
Diluted Normalized EPS	0.17	-0.27	1.43	17.14
Research Development	-	3.06	14.76	12.07
Gain( Loss)on Saleof Assets	-	0.52	-	-
DPS- Common Stock Primary Issue	-	-	1.50	-